A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers

Clinical trial NCT02446301 · COMPLETED

Trial details

NCT number: NCT02446301
Sponsor: Lumosa Therapeutics Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pain Analgesia Disorder

Start date: 2015-01-01
Primary completion: 2015-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.